AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
WASHINGTON -- Without a thorough public education program, ignorance and stigma could stymie any future attempts to vaccinate Americans against human papillomavirus.
"Having a vaccine available doesn't necessarily mean the public will utilize it," Allison Friedman said at a conference on vaccine research sponsored by the National Foundation for Infectious Diseases.
"This may be particularly the case with vaccines for sexually transmitted diseases. There may also be moral opposition to the vaccine, especially if it's to be administered to individuals before they become sexually active," said Ms. Friedman of the Centers for Disease Control and Prevention's (CDC) division of sexually transmitted disease prevention.
Stigma and ignorance of the sequelae of HPV infection aren't the only barriers to public acceptance of any future vaccine, according to a series of 35 focus groups sponsored by the CDC. Participants in those groups also said they would be unlikely to receive a vaccine if it weren't covered by insurance, reasoning that lack of coverage would imply that the vaccine is not important. Other participants expressed concern that giving the vaccine to teenagers would be a license for promiscuity, Ms. Friedman said.
Although no HPV vaccine is currently available, several companies are conducting clinical trials.
The focus groups were conducted as part of a larger study of the public's knowledge, attitudes, and communication preferences regarding sexually transmitted diseases and their prevention. The focus group sessions were conducted in six areas of the United States that have high mortality rates from cervical cancer. The areas were located in Florida, Texas, Georgia, California, North Carolina, and Kansas. Groups were sex-segregated and comprised both married and unmarried adults aged 25-45 years.
Participants were asked four questions about an HPV vaccine: Would they get such a vaccine if it were available? What might encourage or prevent them from getting the vaccine? Should the vaccine be part of the normally recommended schedule? And should it be offered as part of the adult or childhood vaccination schedule?
Source: HighBeam Research, If the HPV vaccine ever becomes available, will patients want to get...